Current Edition

divestment

Novartis CEO Narashimhan confirms interest in purchase of generics unit Sandoz

Amid Novartis’ strategic review of generics unit Sandoz, last month came word that Swedish investment group EQT and the Struengmann brothers of Germany were considering …

Continue Reading →
biotechnology

A Guide for Establishing and Governing Data Collection Standards

Many data management teams report that their standards initiatives have stalled or failed because executives aren’t bought-in, standards are over-proliferated, or they are stuffed with …

Continue Reading →
divestment

Novartis may have a buyer for $21B generics unit Sandoz

Amid the industrywide push by Big Pharmas to spin off their generics and consumer businesses, Novartis may be on the verge of separating itself from …

Continue Reading →